NB-H2

N/A

Report date: 2025/08/22 13:51:53
NME

Base Information

Drug NameNB-H2
Drug Alias NameNB-H2
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsFatty Liver
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySingapore
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNanyang Biologics Pte Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsFatty Liver
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A